Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7661–7680 of 17,529 recalls

March 4, 2019· H J Harkins Company Inc dba Pharma Pac

Recalled Item: Losartan Potassium 100 mg Tablets # 30 Losartan potassium tablets USP

The Issue: CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 4, 2019· Petra Hygienic Systems Int Ltd

Recalled Item: ATHLETICARE Anti-Bacterial Hand Soap AC 550 (triclosan)

The Issue: Does Not Meet Monograph: product contains, triclosan, an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 1, 2019· American Health Packaging

Recalled Item: Aspirin and Extended-release Dipyridamole Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 1, 2019· AVKARE Inc.

Recalled Item: Oxybutynin Chloride Extended-Release Tablets USP 10 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 1, 2019· Apotex Inc.

Recalled Item: Drospirenone and Ethinyl Estradiol Tablets

The Issue: Contraceptive Tablets Out of Sequence: Missing or incorrect

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets

The Issue: CGMP Deviations: FDA lab confirmed presence of an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 28, 2019· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: BuPROPion Hydrochloride Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund